CA3268336A1 - Sang à teneur réduite en oxygène destiné à être utilisé dans le traitement d'un traumatisme crânio-cérébral accompagné d'un choc hémorragique - Google Patents
Sang à teneur réduite en oxygène destiné à être utilisé dans le traitement d'un traumatisme crânio-cérébral accompagné d'un choc hémorragiqueInfo
- Publication number
- CA3268336A1 CA3268336A1 CA3268336A CA3268336A CA3268336A1 CA 3268336 A1 CA3268336 A1 CA 3268336A1 CA 3268336 A CA3268336 A CA 3268336A CA 3268336 A CA3268336 A CA 3268336A CA 3268336 A1 CA3268336 A1 CA 3268336A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- brain injury
- traumatic brain
- hemorrhagic shock
- reduced blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263408460P | 2022-09-20 | 2022-09-20 | |
| US202363583607P | 2023-09-19 | 2023-09-19 | |
| PCT/US2023/074641 WO2024064723A1 (fr) | 2022-09-20 | 2023-09-20 | Sang à teneur réduite en oxygène destiné à être utilisé dans le traitement d'un traumatisme crânio-cérébral accompagné d'un choc hémorragique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3268336A1 true CA3268336A1 (fr) | 2024-03-28 |
Family
ID=88372246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3268336A Pending CA3268336A1 (fr) | 2022-09-20 | 2023-09-20 | Sang à teneur réduite en oxygène destiné à être utilisé dans le traitement d'un traumatisme crânio-cérébral accompagné d'un choc hémorragique |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4590312A1 (fr) |
| CA (1) | CA3268336A1 (fr) |
| IL (1) | IL319716A (fr) |
| WO (1) | WO2024064723A1 (fr) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6447987B1 (en) | 1978-09-09 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Prolonged storage of red blood cells |
| US4769318A (en) | 1986-06-03 | 1988-09-06 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
| US4880786A (en) | 1987-01-14 | 1989-11-14 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
| US5476764A (en) | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
| US5624794A (en) | 1995-06-05 | 1997-04-29 | The Regents Of The University Of California | Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas |
| US6162396A (en) | 1997-04-26 | 2000-12-19 | The Regents Of The University Of California | Blood storage device and method for oxygen removal |
| US5789151A (en) | 1997-05-15 | 1998-08-04 | The Regents Of The University Of California | Prolonged cold storage of red blood cells by oxygen removal and additive usage |
| US6413713B1 (en) | 1998-10-30 | 2002-07-02 | Hyperbaric Systems | Method for preserving blood platelets |
| CN107530377B (zh) | 2015-03-10 | 2021-09-03 | 新健康科学股份有限公司 | 氧减少一次性套件、装置及其使用方法 |
| ES2931228T3 (es) * | 2017-05-19 | 2022-12-27 | Hemanext Inc | Procedimientos y tratamiento de traumatismos |
-
2023
- 2023-09-20 WO PCT/US2023/074641 patent/WO2024064723A1/fr not_active Ceased
- 2023-09-20 IL IL319716A patent/IL319716A/en unknown
- 2023-09-20 EP EP23787293.2A patent/EP4590312A1/fr active Pending
- 2023-09-20 CA CA3268336A patent/CA3268336A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4590312A1 (fr) | 2025-07-30 |
| WO2024064723A1 (fr) | 2024-03-28 |
| IL319716A (en) | 2025-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202014723D0 (en) | Use of cannabinoids in the treatment of epilepsy | |
| RU2016141570A (ru) | Комбинации ингибитора fgfr и ингибитора igf1r | |
| IL315897A (en) | 5-MEO-DMT for use in the treatment of sleep disorders | |
| CA3255640A1 (fr) | 5-meo-dmt pour une utilisation dans le traitement de troubles du sommeil | |
| MX2023014484A (es) | Uso de roluperidona para tratar sintomas y trastornos negativos, aumentar la neuroplasticidad y promover la neuroproteccion. | |
| RS67403B1 (sr) | Sotorasib za upotrebu u lečenju kancera | |
| CA3264923A1 (fr) | Composition destinée à être utilisée dans le traitement de la maladie de fabry | |
| IL319716A (en) | Deoxygenated blood for use in the treatment of traumatic brain injury accompanied by hemorrhagic shock | |
| GB202108690D0 (en) | Use of cannabinoids in the treatment of epilepsy | |
| EP4188498A4 (fr) | Système d'oxygénothérapie connecté pour la prise en charge d'une maladie respiratoire chronique | |
| CA3261529A1 (fr) | Composition d'hydrogel destinée à être utilisée dans le traitement de troubles articulaires | |
| CA3253889A1 (fr) | Analogues de rifabutine pour le traitement d'une maladie | |
| EP4436575A4 (fr) | Alpha-1062 destiné au traitement d'une lésion cérébrale traumatique | |
| PL4146225T3 (pl) | Związki metylotioniniowe do zastosowania w leczeniu hipoksemii | |
| GB202114129D0 (en) | Treatment of traumatic brain injury | |
| GB202107701D0 (en) | Treatment of traumatic brain injury | |
| GB202105648D0 (en) | Treatment of traumatic brain injury | |
| GB202218314D0 (en) | Vitamin a for use in the treatment of traumatic brain injury | |
| GB202006727D0 (en) | Treatment of traumatic brain injury | |
| IL313669A (en) | New analogs of valproic acid and methods of medical treatment with their help | |
| CA3266616A1 (fr) | Traitement d'un traumatisme crânio-cérébral léger | |
| GB202503575D0 (en) | Low dose cannabinoids for use in the treatment of sleep disorders | |
| GB202503453D0 (en) | Compounds for the treatment of skin diseases | |
| GB202403324D0 (en) | Compounds for the treatment of skin diseases | |
| IL324190A (en) | Use of compounds for the prevention or treatment of radiation-induced brain injury |